In the above-named article by Islam MS, Catherino WH, Protic O, Janjusevic M, Gray PC, Giannubilo SR, Ciavattini A, Lamanna P, Tranquilli AL, Petraglia F, Castellucci M, and Ciarmela P (J Clin Endocrinol Metab. 2014;99(5):E775–E785; doi: 10.1210/jc.2013-2623), the following error occurred in Figure 1: the same image was used for myometrium and leiomyoma cells treated with tranilast in panel (A). The corrected panel is shown here.
. 2019 Dec 12;105(1):387–388. doi: 10.1210/clinem/dgz160
CORRIGENDUM FOR “Role of Activin-A and Myostatin and Their Signaling Pathway in Human Myometrial and Leiomyoma Cell Function”
Collection date 2020 Jan.
© Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
PMCID: PMC7947774 PMID: 31832677
This corrects the article "Role of Activin-A and Myostatin and Their Signaling Pathway in Human Myometrial and Leiomyoma Cell Function" in volume 99 on page E775.

